Delta opioid receptor mediated actions in the rostral ventromedial medulla on tail flick latency and nociceptive modulatory neurons

Pain

Volumn 85, Issue 1-2, 2000, Pages 255-262

  Harasawa, Ichiro ^a   Fields, Howard L ^a   Meng, Ian D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Analgesia; Delta opioid receptor; Morphine; OFF cell; ON cell; Pain; Spinal reflex

Indexed keywords

DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; DELTA OPIATE RECEPTOR ANTAGONIST; DELTORPHIN; MORPHINE; NALTRIBEN;

ANALGESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; LATENT PERIOD; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; SPINAL CORD DORSAL HORN; TAIL FLICK TEST;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SPACE; MALE; MEDULLA OBLONGATA; NALTREXONE; NARCOTIC ANTAGONISTS; NEURONS; NOCICEPTORS; OLIGOPEPTIDES; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; RECEPTORS, OPIOID, DELTA;

EID: 0033968982     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(99)00280-8     Document Type: Article

References (50)

1. Azami J., Llewelyn M.B., Roberts M.H. The contribution of nucleus reticularis paragigantocellularis and nucleus raphe magnus to the analgesia produced by systemically administered morphine, investigated with the microinjection technique. Pain. 12:1982;229-246.
2. Arvidsson U., Dado R.J., Reidl M., Lee J.H., Law P.Y., Loh H.H., Elde R., Wessendorf M.W. δ-opioid receptor immunoreactivity: distribution in brainstem and spinal cord, and relationship to biogenic amines and enkephalin. J Neurosci. 15:1995;1215-1235.
3. Basbaum A.I., Fields H.L. Endogenous pain control mechanisms. Ann Neurol. 4:1978;451-462.
4. Bausch S.B., Patterson T.A., Appleyard S.M., Chavkin C. Immunocytochemical localization of delta opioid receptors in mouse brain. J Chem Neuroanat. 8:1995;175-189.
5. Budai D.A. A computer-controlled system for post-stimulus time histogram and wind-up studies. J Neurosci Methods. 51:1994;205-211.
6. Capasso A., Guerrini R., Balboni G., Sorrentino L., Temussi P., Lazarus L.H., Bryant S.D., Salvadori S. Dmt-Tic-OH a highly selective and potent delta-opioid dipeptide receptor antagonist after systemic administration in the mouse. Life Sci. 59:1996;93-98.
7. Cheng Z.-F., Fields H.L., Heinricher M.M. Morphine microinjected into the periaqueductal gray has differential effects on 3 classes of medullary neurons. Brain Res. 375:1986;57-65.
8. Dickenson A.H., Oliveras J.-L., Besson J.-M. Role of the nucleus raphe magnus in opiate analgesia as studied by the microinjection technique in the rat. Brain Res. 170:1979;95-111.
9. Fields H.L., Emson P.C., Leigh B.K., Gilbert R.F., Iversen L.L. Multiple opiate receptor sites on primary afferent fibers. Nature. 284:1980;351-353.
10. Fields H.L., Barbaro N.M., Heinricher M.M. Brainstem neuronal circuitry underlying the antinociceptive action of opiates. Prog Brain Res. 77:1988;245-257.
11. Fields H.L., Heinricher M.M., Mason P. Neurotransmitters in nociceptive modulatory circuits. Annu Rev Neurosci. 14:1991;219-245.
12. Galligan J.J., Mosberg H.I., Hurst R., Hurby V.J., Burke T.F. Cerebral delta opioid receptor mediate analgesia but not the intestinal motility effects of intracerebroventricular administered opioids. J Pharmacol Exp Ther. 229:1984;641-648.
13. Hammond D.L., Wang H., Nakashima N., Basbaum A.I. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-invoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat. J Pharmacol Exp Ther. 284:1998;378-387.
14. Heinricher M.M., Morgan M.M., Fields H.L. Direct and indirect action of morphine on medullary neurons that modulate nociception. Neuroscience. 48:1992;533-543.
15. Heinricher M.M., Morgan M.M., Tortorici V., Fields H.L. Disinhibition of off-cells and antinociception produced by an opioid action within the rostral ventromedial medulla. Neuroscience. 63:1994;279-288.
16. Heyman J.S., Mulvaney S.A., Mosberg H.I., Porreca F. Opioid δ-receptor involvement in supraspinal and spinal antinociception in mice. Brain Res. 420:1987;100-108.
17. Heyman J.S., Jiang Q., Rothman R.B., Mosberg H.I., Porreca F. Modulation of μ-mediated antinociception by δ agonists: characterization with antagonists. Eur J Pharmacol. 169:1989;43-52.
18. Hirakawa N, Tershner SA, Fields HL. Delta opioid antagonists TIPP [ψ] and naltriben in the rostral ventromedial medulla attenuate the antinociceptive effect of the mu opioid receptor agonist DAMGO in the periaqueductal gray. NeuroReport 1999;10:3125-3129.
19. Jensen T.S., Yaksh T.L. III. Comparison of the antinociceptive action of mu and delta opioid receptor ligands in the periaqueductal gray matter, medial and paramedial ventral medulla in the rat as studied by the microinjection technique. Brain Res. 372:1986;301-312.
20. Jiang Q., Mosberg H.I., Porreca F. Antinociceptive effects of [D-Ala2] deltorphin II, a highly selective δ agonist in vivo. Life Sci. 47:1990;43-47.
21. Jiang Q., Takemori A.E., Sultana M., Portoghese P.S., Bowen W.D., Mosberg H.I., Porreca F. Differential antagonism of opioid delta antinociception by [D-Ala2, Leu5, Cys] enkephalin and naltorindole 5′-isothiocynate: evidence for delta receptor subtypes. J Pharmacol Exp Ther. 257:1991;1069-1075.
22. Kest B., Lee C.E., Jenab S., Kao B., Inturrisi C.E. Chronic naltrexone differentially affects supraspinal and delta-opioid receptor-mediated antinociception. Eur J Pharmacol. 345:1998;47-53.
23. Kiefel J.M., Rossi G.C., Bodner R.J. Medullary mu and delta opioid receptors modulate mesencephalic morphine analgesia in rats. Brain Res. 624:1993;151-161.
24. Killian P., Holmes B.B., Takemori A.E., Portoghese P.S., Fujimoto J.M. Cold water swim stress- and delta-2 opioid-induced analgesia are modulated by spinal gamma-aminobutyric acid A receptors. J Pharmacol Exp Ther. 274:1995;730-734.
25. Lord J.A., Waterfield A.A., Hughes J., Kosterlitz H.W. Endogenous opioid peptides: multiple agonists and receptors. Nature. 267:1977;412-438.
26. Mason P., Fields H.L. Axonal trajectories and terinatoins of on- and off-cells in the cat lower brain stem. J Comp Neurol. 288:1989;185-207.
27. McFazdean I. The ionic mechanisms underlying opioid action. Neuropeptides. 11:1988;173-180.
28. Miaskowski C., Taiwo Y.O., Levine J.D. Contribution of supraspinal mu- and delta-opioid receptors to antinociception in the rat. Eur J Pharmacol. 205:1991;247-252.
29. Minami H.I., Satoh M. Molecular biology of the opioid receptors: structures, functions, and distributions. Neurol Res. 23:1995;121-145.
30. Mitchell J.M., Lowe D., Fields H.L. The contribution of the rostral ventromedial medulla to the antinociceptive effects of systemic morphine in restrained and unrestrained rats. Neuroscience. 87:1998;123-133.
31. Moreau J.-L., Fields H.L. Evidence for GABA involvement in midbrain control of medullary neurons that modulate nociceptive transmission. Brain Res. 397:1986;37-46.
32. Mosberg H.I., Hurst R., Hruby V.J., Galligan J.J., Burks T.F., Gee K., Yamamura H.I. [D-Pen2, L-Cys5] enkephalinamide and [D-Pen2, D-Cys5] enkephalamide, conformationally constrained cyclic enkephalinamide analogs with delta receptor specificity. Biophys Res Commun. 106:1982;506-512.
33. Ossipov M.H., Kovelowski C.J., Nichols M.L., Hruby V.J., Porreca F. Characterization of supraspinal antinociceptive actions of opioid delta agonist in the rat Pain. 62:1995;287-293.
34. Pan Z.Z., Fields H.L. Endogenous opioid-mediated inhibition of putative pain-modulating neurons in rat rostral ventromedial medulla. Neuroscience. 74:1996;855-862.
35. Pan Z.Z., Williams J.T., Osborne P.B. Opioid actions on single nucleus raphe magnus neurons from rat and guinea-pig in vitro. J Physiol (Lond). 427:1990;519-532.
36. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1986;Academic Press, New York.
37. Porreca F., Mosberg H.I., Hurst R., Hruby V.J., Burks T.F. Roles of mu, delta, and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse. J Pharmacol Exp Ther. 230:1984;341-348.
38. Rodriguez R.E., Leighton G., Hill R.G., Hughes J. In vivo evidence for spinal delta-opiate receptor-operated antinociception. Neuropeptides. 8:1986;221-241.
39. Roychowdhury S.M., Fields H.L. Endogenous opioids acting a medullary mu-opioid receptor contribute to the behavioral antinociception produced by GABA antagonism in the midbrain periaqueductal gray. Neuroscience. 74:1996;863-872.
40. Sanchez-Blanquez P., Garzon J. Delta opioid receptor subtypes activate inositol-signaling pathways in the production of antinociception. J Pharmacol Exp Ther. 285:1998;820-827.
41. Satoh M., Kubota A., Iwama T., Wada T., Yasui M., Fujibayashi K., Takagi H. Comparison of analgesia potencies of mu, delta, and kappa agonists locally applied to various CNS regions relevant to analgesia in rats. Life Sci. 33:(Suppl 1):1983;689-692.
42. Schmauss C., Yaksh T.L. In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta, kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat. J Pharmacol Exp Ther. 228:1984;1-12.
43. Skagerberg G., Björklund A. Topographic principles in the spinal projections of serotonergic and non-serotonergic brainstem neurons in the rat. Neuroscience. 15:1985;445-480.
44. Sofuoglu M., Portoghese P.S., Takemori A.E. Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes. J Pharmacol Exp Ther. 257:1991;676-680.
45. Sofuoglu M., Portoghese P.S., Takemori A.E. Delta-opioid receptor binding in mouse brain: evidence for heterogenous binding sites. Eur J Pharmacol. 216:1992;273-277.
46. Stewart P.E., Hammond D.L. Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic [D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4] deltorphin. J Pharmacol Exp Ther. 266:1993;820-828.
47. Suh H.H., Tseng L.F. Different types of opioid receptors mediating analgesia induced by morphine, DAMGO, DPDPE, DADLE, and β-endorphin in mice. Naunyn-Schmiedeberg's Arch Pharmacol. 342:1990;67-71.
48. Thorat J.R., Hammond D.L. Modulation of nociception by microinjection of delta-1 and delta-2 opioid ligands in the ventromedial medulla of the rat. J Pharmacol Exp Ther. 283:1997;1185-1192.
49. Traynor J.R., Elliott J. Delta-opioid receptor subtypes and cross-talk with mu-receptors. Trends Pharmacol Sci. 14:1993;84-86.
50. Vanderah T.W., Wild K.D., Takemori A.E., Sultana M., Portoghese P.S., Bowen W.D., Mosberg H.I., Porreca F. Mediation of swim-stress antinociception by the opioid delta-2 receptor in the mouse. J Pharmacol Exp Ther. 262:1992;190-197.